![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: RPS6KA1 |
Gene summary for RPS6KA1 |
![]() |
Gene information | Species | Human | Gene symbol | RPS6KA1 | Gene ID | 6195 |
Gene name | ribosomal protein S6 kinase A1 | |
Gene Alias | HU-1 | |
Cytomap | 1p36.11 | |
Gene Type | protein-coding | GO ID | GO:0001558 | UniProtAcc | Q15418 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
6195 | RPS6KA1 | HTA11_2487_2000001011 | Human | Colorectum | SER | 4.60e-03 | 4.38e-01 | -0.1808 |
6195 | RPS6KA1 | HTA11_347_2000001011 | Human | Colorectum | AD | 2.67e-12 | 4.34e-01 | -0.1954 |
6195 | RPS6KA1 | HTA11_2112_2000001011 | Human | Colorectum | SER | 4.54e-05 | 8.47e-01 | -0.2196 |
6195 | RPS6KA1 | HTA11_3361_2000001011 | Human | Colorectum | AD | 3.20e-03 | 4.04e-01 | -0.1207 |
6195 | RPS6KA1 | HTA11_83_2000001011 | Human | Colorectum | SER | 9.79e-04 | 3.31e-01 | -0.1526 |
6195 | RPS6KA1 | HTA11_696_2000001011 | Human | Colorectum | AD | 2.41e-04 | 4.25e-01 | -0.1464 |
6195 | RPS6KA1 | HTA11_866_2000001011 | Human | Colorectum | AD | 2.96e-04 | 3.66e-01 | -0.1001 |
6195 | RPS6KA1 | HTA11_1391_2000001011 | Human | Colorectum | AD | 2.42e-07 | 6.00e-01 | -0.059 |
6195 | RPS6KA1 | HTA11_2992_2000001011 | Human | Colorectum | SER | 4.97e-02 | 4.67e-01 | -0.1706 |
6195 | RPS6KA1 | A015-C-203 | Human | Colorectum | FAP | 8.53e-07 | -4.26e-02 | -0.1294 |
6195 | RPS6KA1 | A001-C-108 | Human | Colorectum | FAP | 7.06e-03 | -8.09e-02 | -0.0272 |
6195 | RPS6KA1 | A002-C-205 | Human | Colorectum | FAP | 4.50e-04 | -1.97e-01 | -0.1236 |
6195 | RPS6KA1 | A015-C-104 | Human | Colorectum | FAP | 8.30e-08 | -6.52e-02 | -0.1899 |
6195 | RPS6KA1 | A001-C-014 | Human | Colorectum | FAP | 6.85e-03 | -8.23e-02 | 0.0135 |
6195 | RPS6KA1 | A002-C-016 | Human | Colorectum | FAP | 6.74e-06 | -1.31e-01 | 0.0521 |
6195 | RPS6KA1 | A002-C-116 | Human | Colorectum | FAP | 3.21e-09 | -1.99e-01 | -0.0452 |
6195 | RPS6KA1 | A018-E-020 | Human | Colorectum | FAP | 8.93e-03 | -4.09e-02 | -0.2034 |
6195 | RPS6KA1 | F034 | Human | Colorectum | FAP | 6.15e-05 | -1.31e-01 | -0.0665 |
6195 | RPS6KA1 | CRC-1-8810 | Human | Colorectum | CRC | 1.74e-04 | -1.95e-01 | 0.6257 |
6195 | RPS6KA1 | CRC-3-11773 | Human | Colorectum | CRC | 4.34e-04 | -9.93e-02 | 0.2564 |
Page: 1 2 3 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0048732 | Colorectum | AD | gland development | 149/3918 | 436/18723 | 6.07e-11 | 6.33e-09 | 149 |
GO:0006417 | Colorectum | AD | regulation of translation | 141/3918 | 468/18723 | 1.32e-06 | 4.22e-05 | 141 |
GO:0016049 | Colorectum | AD | cell growth | 143/3918 | 482/18723 | 2.83e-06 | 8.09e-05 | 143 |
GO:0043281 | Colorectum | AD | regulation of cysteine-type endopeptidase activity involved in apoptotic process | 72/3918 | 209/18723 | 3.70e-06 | 1.03e-04 | 72 |
GO:2000116 | Colorectum | AD | regulation of cysteine-type endopeptidase activity | 79/3918 | 235/18723 | 3.74e-06 | 1.03e-04 | 79 |
GO:0052547 | Colorectum | AD | regulation of peptidase activity | 137/3918 | 461/18723 | 4.12e-06 | 1.12e-04 | 137 |
GO:0061008 | Colorectum | AD | hepaticobiliary system development | 55/3918 | 150/18723 | 6.34e-06 | 1.59e-04 | 55 |
GO:0001889 | Colorectum | AD | liver development | 54/3918 | 147/18723 | 7.20e-06 | 1.77e-04 | 54 |
GO:0001558 | Colorectum | AD | regulation of cell growth | 124/3918 | 414/18723 | 7.67e-06 | 1.86e-04 | 124 |
GO:0045861 | Colorectum | AD | negative regulation of proteolysis | 106/3918 | 351/18723 | 2.33e-05 | 4.57e-04 | 106 |
GO:0052548 | Colorectum | AD | regulation of endopeptidase activity | 124/3918 | 432/18723 | 6.58e-05 | 1.07e-03 | 124 |
GO:0022612 | Colorectum | AD | gland morphogenesis | 42/3918 | 118/18723 | 1.62e-04 | 2.23e-03 | 42 |
GO:0043620 | Colorectum | AD | regulation of DNA-templated transcription in response to stress | 23/3918 | 53/18723 | 1.86e-04 | 2.49e-03 | 23 |
GO:0043154 | Colorectum | AD | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process | 30/3918 | 78/18723 | 2.95e-04 | 3.59e-03 | 30 |
GO:0030307 | Colorectum | AD | positive regulation of cell growth | 54/3918 | 166/18723 | 3.08e-04 | 3.69e-03 | 54 |
GO:0045927 | Colorectum | AD | positive regulation of growth | 77/3918 | 259/18723 | 4.82e-04 | 5.27e-03 | 77 |
GO:2000117 | Colorectum | AD | negative regulation of cysteine-type endopeptidase activity | 31/3918 | 86/18723 | 8.67e-04 | 8.45e-03 | 31 |
GO:0050673 | Colorectum | AD | epithelial cell proliferation | 119/3918 | 437/18723 | 8.75e-04 | 8.51e-03 | 119 |
GO:0018105 | Colorectum | AD | peptidyl-serine phosphorylation | 88/3918 | 315/18723 | 1.73e-03 | 1.43e-02 | 88 |
GO:0018209 | Colorectum | AD | peptidyl-serine modification | 92/3918 | 338/18723 | 3.19e-03 | 2.36e-02 | 92 |
Page: 1 2 3 4 5 6 7 8 9 10 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa04714 | Colorectum | AD | Thermogenesis | 120/2092 | 232/8465 | 2.76e-19 | 1.16e-17 | 7.37e-18 | 120 |
hsa05135 | Colorectum | AD | Yersinia infection | 58/2092 | 137/8465 | 3.90e-06 | 4.35e-05 | 2.78e-05 | 58 |
hsa04722 | Colorectum | AD | Neurotrophin signaling pathway | 50/2092 | 119/8465 | 2.28e-05 | 2.24e-04 | 1.43e-04 | 50 |
hsa047141 | Colorectum | AD | Thermogenesis | 120/2092 | 232/8465 | 2.76e-19 | 1.16e-17 | 7.37e-18 | 120 |
hsa051351 | Colorectum | AD | Yersinia infection | 58/2092 | 137/8465 | 3.90e-06 | 4.35e-05 | 2.78e-05 | 58 |
hsa047221 | Colorectum | AD | Neurotrophin signaling pathway | 50/2092 | 119/8465 | 2.28e-05 | 2.24e-04 | 1.43e-04 | 50 |
hsa047142 | Colorectum | SER | Thermogenesis | 106/1580 | 232/8465 | 1.15e-21 | 6.34e-20 | 4.61e-20 | 106 |
hsa051352 | Colorectum | SER | Yersinia infection | 43/1580 | 137/8465 | 2.15e-04 | 2.10e-03 | 1.52e-03 | 43 |
hsa047222 | Colorectum | SER | Neurotrophin signaling pathway | 35/1580 | 119/8465 | 2.80e-03 | 2.02e-02 | 1.47e-02 | 35 |
hsa047202 | Colorectum | SER | Long-term potentiation | 21/1580 | 67/8465 | 8.52e-03 | 4.26e-02 | 3.09e-02 | 21 |
hsa047143 | Colorectum | SER | Thermogenesis | 106/1580 | 232/8465 | 1.15e-21 | 6.34e-20 | 4.61e-20 | 106 |
hsa051353 | Colorectum | SER | Yersinia infection | 43/1580 | 137/8465 | 2.15e-04 | 2.10e-03 | 1.52e-03 | 43 |
hsa047223 | Colorectum | SER | Neurotrophin signaling pathway | 35/1580 | 119/8465 | 2.80e-03 | 2.02e-02 | 1.47e-02 | 35 |
hsa047203 | Colorectum | SER | Long-term potentiation | 21/1580 | 67/8465 | 8.52e-03 | 4.26e-02 | 3.09e-02 | 21 |
hsa047148 | Colorectum | FAP | Thermogenesis | 70/1404 | 232/8465 | 1.38e-07 | 3.08e-06 | 1.87e-06 | 70 |
hsa051356 | Colorectum | FAP | Yersinia infection | 43/1404 | 137/8465 | 1.21e-05 | 1.62e-04 | 9.86e-05 | 43 |
hsa047226 | Colorectum | FAP | Neurotrophin signaling pathway | 38/1404 | 119/8465 | 2.49e-05 | 2.78e-04 | 1.69e-04 | 38 |
hsa049312 | Colorectum | FAP | Insulin resistance | 32/1404 | 108/8465 | 4.90e-04 | 3.56e-03 | 2.16e-03 | 32 |
hsa04010 | Colorectum | FAP | MAPK signaling pathway | 68/1404 | 302/8465 | 4.00e-03 | 1.67e-02 | 1.02e-02 | 68 |
hsa047206 | Colorectum | FAP | Long-term potentiation | 20/1404 | 67/8465 | 4.82e-03 | 1.91e-02 | 1.16e-02 | 20 |
Page: 1 2 3 4 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
RPS6KA1 | SNV | Missense_Mutation | novel | c.658N>C | p.Glu220Gln | p.E220Q | Q15418 | protein_coding | tolerated(0.13) | benign(0.281) | TCGA-HD-8635-01 | Oral cavity | head & neck squamous cell carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
RPS6KA1 | SNV | Missense_Mutation | novel | c.1721N>A | p.Arg574Gln | p.R574Q | Q15418 | protein_coding | deleterious(0.02) | probably_damaging(0.952) | TCGA-HD-A6I0-01 | Oral cavity | head & neck squamous cell carcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
RPS6KA1 | insertion | Frame_Shift_Ins | novel | c.1313_1314insCT | p.Glu440LeufsTer46 | p.E440Lfs*46 | Q15418 | protein_coding | TCGA-HD-A6I0-01 | Oral cavity | head & neck squamous cell carcinoma | Male | <65 | I/II | Unknown | Unknown | SD | ||
RPS6KA1 | SNV | Missense_Mutation | c.947N>T | p.Ser316Phe | p.S316F | Q15418 | protein_coding | deleterious(0.01) | benign(0.089) | TCGA-KK-A6E7-01 | Prostate | prostate adenocarcinoma | Male | <65 | 9 | Unknown | Unknown | PD | |
RPS6KA1 | SNV | Missense_Mutation | rs774987391 | c.70C>T | p.Arg24Trp | p.R24W | Q15418 | protein_coding | deleterious_low_confidence(0.01) | benign(0.157) | TCGA-XK-AAIW-01 | Prostate | prostate adenocarcinoma | Male | >=65 | 9 | Unknown | Unknown | PD |
RPS6KA1 | SNV | Missense_Mutation | novel | c.1756A>G | p.Thr586Ala | p.T586A | Q15418 | protein_coding | deleterious(0) | probably_damaging(0.912) | TCGA-XK-AAIW-01 | Prostate | prostate adenocarcinoma | Male | >=65 | 9 | Unknown | Unknown | PD |
RPS6KA1 | SNV | Missense_Mutation | rs779820707 | c.1022N>A | p.Arg341His | p.R341H | Q15418 | protein_coding | deleterious(0) | possibly_damaging(0.879) | TCGA-BR-4201-01 | Stomach | stomach adenocarcinoma | Female | >=65 | I/II | Chemotherapy | cisplatin | SD |
RPS6KA1 | SNV | Missense_Mutation | rs760553222 | c.1615N>C | p.Gly539Arg | p.G539R | Q15418 | protein_coding | deleterious(0.02) | possibly_damaging(0.589) | TCGA-BR-4371-01 | Stomach | stomach adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
RPS6KA1 | SNV | Missense_Mutation | c.470N>T | p.Asp157Val | p.D157V | Q15418 | protein_coding | deleterious(0) | probably_damaging(0.913) | TCGA-BR-6452-01 | Stomach | stomach adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
RPS6KA1 | SNV | Missense_Mutation | c.1586N>A | p.Gly529Asp | p.G529D | Q15418 | protein_coding | deleterious(0.02) | benign(0.433) | TCGA-CG-4437-01 | Stomach | stomach adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
6195 | RPS6KA1 | SERINE THREONINE KINASE, KINASE, ENZYME, DRUGGABLE GENOME, TRANSCRIPTION FACTOR | 1,6-diazanaphthalenes and pyrido[2,3-d] pyrimidine derivative 1 | |||
6195 | RPS6KA1 | SERINE THREONINE KINASE, KINASE, ENZYME, DRUGGABLE GENOME, TRANSCRIPTION FACTOR | inhibitor | 385612197 | ||
6195 | RPS6KA1 | SERINE THREONINE KINASE, KINASE, ENZYME, DRUGGABLE GENOME, TRANSCRIPTION FACTOR | 1,6-diazanaphthalenes and pyrido[2,3-d] pyrimidine derivative 2 | |||
6195 | RPS6KA1 | SERINE THREONINE KINASE, KINASE, ENZYME, DRUGGABLE GENOME, TRANSCRIPTION FACTOR | inhibitor | 249565718 | CHEMBL573107 | |
6195 | RPS6KA1 | SERINE THREONINE KINASE, KINASE, ENZYME, DRUGGABLE GENOME, TRANSCRIPTION FACTOR | inhibitor | 178101606 | DORSOMORPHIN | |
6195 | RPS6KA1 | SERINE THREONINE KINASE, KINASE, ENZYME, DRUGGABLE GENOME, TRANSCRIPTION FACTOR | inhibitor | 249565843 | ||
6195 | RPS6KA1 | SERINE THREONINE KINASE, KINASE, ENZYME, DRUGGABLE GENOME, TRANSCRIPTION FACTOR | inhibitor | HESPERADIN | HESPERADIN | 19035792 |
6195 | RPS6KA1 | SERINE THREONINE KINASE, KINASE, ENZYME, DRUGGABLE GENOME, TRANSCRIPTION FACTOR | Pyrrolo[2,3-d]pyrimidine derivative 2 | |||
6195 | RPS6KA1 | SERINE THREONINE KINASE, KINASE, ENZYME, DRUGGABLE GENOME, TRANSCRIPTION FACTOR | BI-D1870 | CHEMBL573107 | ||
6195 | RPS6KA1 | SERINE THREONINE KINASE, KINASE, ENZYME, DRUGGABLE GENOME, TRANSCRIPTION FACTOR | Pyrrolo[2,3-d]pyrimidine derivative 1 |
Page: 1 2 |